Home/ Supplements/ Vitamin K/ Natural Vitamin K2 MK-7 with MenaQ7 100 ...

Natural Vitamin K2 MK-7 with MenaQ7 100 mcg

product on market Capsule Doctor's Best Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 MK-7 is supported by moderate evidence for promoting calcium homeostasis by directing minerals into the bones and away from arteries. Research indicates it works synergistically with Vitamin D to support cardiovascular and skeletal health. The ingredient profile maintains a high safety rating for general use.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Natural Vitamin K2 MK-7 with MenaQ7 100 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Veggie Capsule(s)
Serving Size
60
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mcg (80% DV)
Within RDA (0.8× RDA) 275 studies (A:9, B:175)

Other Ingredients

Microcrystalline Cellulose Modified Cellulose Glycerol Monostearate Magnesium Stearate Ascorbyl Palmitate Rosemary extract
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Adult Use: Take 1 capsule daily with food, or as recommended by a nutritionally-informed physician.

Warnings & Precautions

Warning: This product contains vitamin K.

Warning: This product contains vitamin K. Consult your physician if using blood-thinning medications such as Warfarin.

Formulation Notes

Doctor's Best Natural Vitamin K2 MK-7 with MenaQ7 provides the natural form of vitamin K for optimum bioavailability and delivery to the body. Vitamin K isn't one vitamin, it's a family of fat-soluble vitamins with similar chemical structures but different metabolic properties. K2 belongs to a group of vitamin K compounds called menaquinones, which show greater bioactivity when compared to K1, the ordinary supplemental form. K2 is absorbed more completely, remains in the body longer and delivers more benefits for bones, blood vessels and other soft tissues.

Highly effective delivery of vitamin K to bone and soft tissue

Vitamin K2 as MK-7

The bioavailable form of vitamin K for healthy bones and soft tissue

Non-GMO Gluten Free Soy Free

Vegan

Additional Information

Helps support bone health and soft tissue elasticity Helps support calcium metabolism for maintenance of healthy bone

YDRB334-3

Vegan

Store in a cool dry place.

Metadata

Product Details

UPC / SKU7 53950 00334 7
DSLD Entry Date2019-06-24
Product TypeVitamin
FormCapsule
DSLD ID203346
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.